Home Spectrum Pharmaceuticals

Spectrum Pharmaceuticals

acquired
Post-IPO Round
Developer of Novel Targeted Cancer Therapies
Basic
Enterprise Profile

Basic Information

Spectrum Pharmaceuticals is a biopharmaceutical company focused on acquiring, developing, and commercializing novel targeted drug products, primarily concentrating on hematology and oncology. Spectrum has a strong track record in licensing and acquiring differentiated drugs as well as clinical development. Spectrum possesses a late-stage pipeline with the potential to transform the company.
Spectrum Pharmaceuticals, Inc.
Nevada,United States of America
51~100 people
January 01, 2002
compliance@sppirx.com

Enterprise Profile

Industrial Sector
New Drug Development
Technology
Biotechnology
Concept
Therapeutic Products Lung Cancer
Application Scenarios
Targeted drugs Innovative Drugs